A micromorphometry‐based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma

The sentinel lymph nodes (SLNs) as the primary targets for lymphatic metastases can be removed selectively by γ probe‐guided sentinel lymph nodectomy (SLNE) in nearly all patients with cutaneous melanoma. Correspondingly high standards in terms of specificity, sensitivity, and microstaging are required for the evaluation of SLNs.

[1]  B. Majumder.  Reliability of sentinel lymph node biopsy for staging melanoma , 2000, The British journal of surgery.

[2]  C. Garbe,et al.  Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. , 2000, The Journal of investigative dermatology.

[3]  Martin F. Mihm,et al.  A new American Joint Committee on Cancer staging system for cutaneous melanoma , 2000, Cancer.

[4]  Jeffrey E. Lee,et al.  Role for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Thick (≥4 mm) Primary Melanoma , 2000, Annals of Surgical Oncology.

[5]  D L Morton,et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.

[6]  M. Mihm,et al.  Detection of microscopic melanoma metastases in sentinel lymph nodes , 1999, Cancer.

[7]  V. Sondak,et al.  Recent Advances in Melanoma Staging and Therapy , 1999, Annals of Surgical Oncology.

[8]  D. Reintgen,et al.  Pathologic examination of the sentinel lymph node in malignant melanoma. , 1999, The American journal of surgical pathology.

[9]  J. J. Coleman,et al.  Lymph Node Tumor Volumes in Patients Undergoing Sentinel Lymph Node Biopsy for Cutaneous Melanoma , 1999, Annals of Surgical Oncology.

[10]  J. J. Coleman,et al.  Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Coit,et al.  Detection of Tyrosinase mRNA by Reverse Transcription Polymerase Chain Reaction in Melanoma Sentinel Nodes , 1999, Annals of Surgical Oncology.

[12]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  N. Cascinelli,et al.  Sentinel node biopsy and selective lymph node dissection in cutaneous melanoma patients. , 1999, Journal of experimental & clinical cancer research : CR.

[14]  J. Cheville,et al.  Cancer volume of lymph node metastasis predicts progression in prostate cancer. , 1998, The American journal of surgical pathology.

[15]  G. Lyman,et al.  Molecular staging of malignant melanoma: correlation with clinical outcome. , 1998, JAMA.

[16]  S. Leong,et al.  Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. , 1998, Archives of dermatology.

[17]  H. Vogt,et al.  Primary therapy of malignant melanomas: sentinel lymphadenectomy. , 1998, International journal of dermatology.

[18]  N. Cascinelli,et al.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial , 1998, The Lancet.

[19]  B. Balda,et al.  Sentinel-Lymphonodektomie bei malignen Melanomen. Eine vorläufige Bilanz aus histomorphologischer Sicht , 1998 .

[20]  A. Cochran,et al.  Prediction of outcome for patients with cutaneous melanoma. , 2003, Pigment cell research.

[21]  Otto S. Hoekstra,et al.  Sentinel Node Biopsy in Melanoma Patients: Dynamic Lymphoscintigraphy Followed by Intraoperative Gamma Probe and Vital Dye Guidance , 1997, World Journal of Surgery.

[22]  D. Coit,et al.  Sentinel lymph node evaluation in melanoma. , 1997, Archives of dermatology.

[23]  H. Vogt,et al.  ["Sentinel" lymphonodectomy with scintillation detector. A new strategy in treatment of malignant melanoma]. , 1996, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[24]  H. Vogt,et al.  Die „sentinel“ Lymphonodektomie mittels Szintillationsdetektor Eine neue Strategie in der Behandlung maligner Melanome , 1996, Der Hautarzt.

[25]  A. Cochran,et al.  Nodal nevi and cutaneous melanomas. , 1996, The American journal of surgical pathology.

[26]  H. Baum,et al.  Rapid and unbiased estimation of the volume of cutaneous malignant melanoma using Cavalieri's principle. , 1996, The American Journal of dermatopathology.

[27]  D. Reintgen,et al.  The Role of Selective Lymphadenectomy in the Management of Patients with Malignant Melanoma , 1995, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[28]  C. O'brien,et al.  Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes , 1995, Melanoma research.

[29]  D. Weaver,et al.  Minimal-access surgery for staging of malignant melanoma. , 1995, Archives of surgery.

[30]  D. Reintgen,et al.  Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma , 1994, Annals of surgery.

[31]  M. Ross,et al.  The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.

[32]  C. Garbe,et al.  [Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94]. , 1994, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[33]  C. Garbe,et al.  Stellungnahme und Empfehlungen der Kommission malignes Melanom der Deutschen Dermatologischen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut , 1994, Der Hautarzt.

[34]  R. Elashoff,et al.  Application of multistage markov modeling to malignant melanoma progression , 1994, Cancer.

[35]  D. Weaver,et al.  Gamma-probe-guided lymph node localization in malignant melanoma. , 1993, Surgical oncology.

[36]  D. Krag,et al.  Gamma-probe guided localization of lymph nodes. , 1993, Surgical oncology.

[37]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[38]  A. Cochran,et al.  Histomorphometry in the Assessment of Prognosis in Stage II Malignant Melanoma , 1989, The American journal of surgical pathology.

[39]  C. Balch,et al.  The prognostic significance of ulceration of cutaneous melanoma , 1980, Cancer.

[40]  A Breslow,et al.  Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.